Day: March 2, 2021

SASKATOON, Saskatchewan, March 02, 2021 (GLOBE NEWSWIRE) — 1844 RESOURCES LTD. (TSX-V:EFF) (the “Company” or “1844”) , is pleased to announce that Forage Val d’Or Inc. equipment is mobilized on the Lac Arsenault project and the diamond drilling campaign has started. The campaign includes 13 core holes totaling approximately 2,000 meters, targeting the lateral and depth extensions of known mineralized zones.This campaign follows on from the mapping work and the positive results of the induced polarization geophysical survey carried out on the Lac Arsenault property. The combination allowed us to identify and interpret that the polymetallic mineralized zones that are enriched with gold develop along sinister deformation corridors, forming mineralized panels, oriented N/NE and composed of shear veins and folded veins. The chargeability...

WILMETTE, Ill., March 02, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced it has entered into an agreement with serial medtech entrepreneur, Andrew Cittadine, to explore over the next few months strategic and developmental options for MNPR-101 as an intraoperative imaging agent in bladder cancer surgery as well as other cancers.Mr. Cittadine is an experienced healthcare executive with a track record of building new businesses from concept through acquisition, including successful exits of Sensant Corp. to Siemens and American Biooptics to Olympus. Mr. Cittadine was the co-founder and Vice President of Marketing at Sensant...

LORDSTOWN, Ohio, March 02, 2021 (GLOBE NEWSWIRE) — Lordstown Motors Corp. (Nasdaq: RIDE), (“Lordstown Motors”), a leader in electric light duty trucks focused on the commercial fleet market, has entered into a set of agreements with Holman Enterprises, a global automotive services organization, including a co-marketing agreement and vehicle procurement agreement with ARI, Holman’s industry-leading leasing and fleet management services division, and an upfit services agreement with Auto Truck Group, Holman Enterprises’ vehicle fabrication and upfitting division. Together, Holman Enterprises and Lordstown Motors will help organizations easily integrate the Lordstown Endurance, the first all-electric commercial pickup truck, into their vocational fleet operations.The co-marketing agreement establishes the framework to co-develop...

WASHINGTON, March 02, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Miriam Wrobel as a Senior Managing Director in the Power & Renewables practice within the Corporate Finance & Restructuring segment at FTI Consulting, enhancing the firm’s clean energy strategic advisory offerings for clients throughout the deal lifecycle.Ms. Wrobel, who is based in San Francisco, is an expert in renewable energy strategy and finance, advising utilities, equity investors, lenders, project developers and large energy users on strategies for balancing risk and optimizing returns in energy transactions. At FTI Consulting, she will advise clients on energy transformation strategy, transaction structuring, diligence, ESG disclosure strategies and energy procurement.As energy markets evolve to be...

SAN FRANCISCO, March 02, 2021 (GLOBE NEWSWIRE) — APPlife Digital Solutions, Inc. (OTCQB: ALDS) (“APPlife”, the Company”), a business incubator and portfolio manager that invests in and creates e-commerce and cloud-based solutions announced today that it has executed its previously announced letter of intent and signed a definitive agreement (“Agreement”) with Global Hemp Service LLC (“Global”). The Agreement provides Global with a perpetual, royalty-free, non-exclusive license to use APPlife’s market-ready and mobile website e-commerce platform to market, distribute, and sell its hemp, cannabidiol (“CBD”) and other related B2B and B2C products.As part of the Agreement, Global will pay APPlife a fee of 2.5% of its gross revenues, distributed on a quarterly basis. Additionally, APPlife will receive a total of 15% of the outstanding...

Consistent with prior two interim analyses, FURI results confirm positive clinical activity of oral ibrexafungerp in patients with difficult-to-treat, severe, mucocutaneous and invasive fungal infections, including those caused by resistant strains1stInterim analysis of CARES study shows strong clinical activity of oral ibrexafungerp in patients with Candida auris, a high-mortality infection classified by CDC as an Urgent Threat to public healthResults support continued enrollment in both studies, with potential future submissions under the LPAD regulatory pathwayConference call to be held March 2nd, 2021 at 8:30 a.m. ETJERSEY CITY, N.J., March 02, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections,...

MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial and operating results for the fourth quarter and full year of 2020.Fourth Quarter 2020 HighlightsFourth quarter 2020 revenue of $15.6 million, compared to $17.4 million in fourth quarter 2019, primarily due to the impact of the COVID-19 pandemicFourth quarter 2020 revenue increased $3.1 million, or 25%, compared to third quarter 2020Fourth quarter 2020 U.S. treatment session revenue of $11.0 million, compared to $11.2 million in fourth quarter 2019Fourth quarter 2020 U.S. NeuroStar® Advanced Therapy revenue of $3.6 million, compared to...

~ RECORLEV® (levoketoconazole) New Drug Application is Supported by Previously-Reported Positive and Statistically Significant Results from the Phase 3 SONICS and LOGICS Studies ~~ Nearly 40 Percent of Prescription-Treated Endogenous Cushing’s Syndrome Patients in the U.S. Are Not Well-Controlled, Underscoring Need for New, Safe and Effective Pharmaceutical Options to Help Regulate Cortisol Levels ~~ If Approved Following a Projected 10-Month Review Cycle, RECORLEV is Anticipated to Launch in First Quarter of 2022 ~DUBLIN, Ireland and TREVOSE, Pa., March 02, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it submitted a New Drug...

SALT LAKE CITY, March 02, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a new strategic precision oncology collaboration with Intermountain Precision Genomics, a service of Intermountain Healthcare. This collaboration creates a comprehensive germline genetic testing and somatic tumor offering that combines Myriad’s advanced hereditary cancer and companion diagnostic tests with Intermountain Precision Genomics’ world-class laboratory services, utilizing the TheraMap® test—powered by the TruSight™ Oncology 500 (TSO 500) next-generation sequencing test from Illumina, Inc. (NASDAQ: ILMN).TSO 500 is rapidly becoming a standard in oncology. Through the offering, oncologists will obtain a complete genetic analysis in one, easy-to-interpret report, enabling...

ANN ARBOR, Mich., March 02, 2021 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that the University of Notre Dame has been granted a Canadian patent on spider silk technology developed pursuant to the collaborative research agreement with Kraig. This patent further protects Kraig’s growing portfolio of spider silk Intellectual Property.Patent number 2,812,791, titled “Chimeric Spider Silk and Uses Thereof” was issued to the University of Notre Dame (UND) under the Company’s exclusive license agreement. Under the terms of that agreement, the Company paid for the development of the technology and the costs of patents issued to UND in...